Advocate Group LLC Astrazeneca PLC Transaction History
Advocate Group LLC
- $531 Million
- Q4 2024
A detailed history of Advocate Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Advocate Group LLC holds 12,686 shares of AZN stock, worth $933,435. This represents 0.16% of its overall portfolio holdings.
Number of Shares
12,686
Previous 12,692
0.05%
Holding current value
$933,435
Previous $988,000
15.89%
% of portfolio
0.16%
Previous 0.18%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...